The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Muscle force during an acute exacerbation in hospitalised patients with COPD and its relationship with CXCL8 and IGF-I
Open accessAbstract
BACKGROUND: Chronic obstructive pulmonary disease (COPD) is often associated with peripheral muscle weakness, which is caused by several factors. Acute exacerbations may contribute, but their impact on muscle force remains unclear. Correlations between peripheral muscle force and inflammatory and anabolic markers have never been studied in COPD. The effect of an acute exacerbation on quadriceps peak torque (QPT) was therefore studied in hospitalised patients, and the aforementioned correlations were examined in hospitalised and in stable patients. METHODS: Lung function, respiratory and peripheral muscle force, and inflammatory and anabolic markers were assessed in hospitalised patients on days 3 and 8 of the hospital admission and 90 days later. The results on day 3 (n=34) were compared with those in clinically stable outpatients (n=13) and sedentary healthy elderly subjects (n=10). RESULTS: Hospitalised patients had lowest mean (SD) QPT (66 (22)% predicted) and highest median (IQR) levels of systemic interleukin-8 (CXCL8, 6.1 (4.5 to 8.3) pg/ml). Insulin-like growth factor I (IGF-I) tended to be higher in healthy elderly subjects (p=0.09). QPT declined between days 3 and 8 in hospital (mean -5% predicted (95% CI -22 to 8)) and partially recovered 90 days after admission to hospital (mean 6% predicted (95% CI -1 to 23)). QPT was negatively correlated with CXCL8 and positively correlated with IGF-I and lung transfer factor in hospitalised and in stable patients. CONCLUSIONS: Peripheral muscle weakness is enhanced during an acute exacerbation of COPD. CXCL8 and IGF-I may be involved in the development of peripheral muscle weakness in hospitalised and in stable patients with COPD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lung volumes and forced ventilatory flows
Quanjer, P. H., Tammeling, G. J., Cotes, J. E., Pedersen, O. F., Peslin, R., & Yernault, J.-C. (1993) · European Respiratory Journal · doi:10.1183/09041950.005s1693 · Cited by 5,318
(1993) · PubMed · Cited by 3,827
Antibiotic Therapy in Exacerbations of Chronic Obstructive Pulmonary Disease
ANTHONISEN, N. R., MANFREDA, J., WARREN, C. P. W., HERSHFIELD, E. S., HARDING, G. K. M., & NELSON, N. A. (1987) · Annals of Internal Medicine · doi:10.7326/0003-4819-106-2-196 · Cited by 2,492
Effect of Exacerbation on Quality of Life in Patients with Chronic Obstructive Pulmonary Disease
SEEMUNGAL, T. A. R., DONALDSON, G. C., PAUL, E. A., BESTALL, J. C., JEFFRIES, D. J., & WEDZICHA, J. A. (1998) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.157.5.9709032 · Cited by 2,312
Grip and pinch strength: normative data for adults.
Mathiowetz, V. G., Kashman, N., Volland, G., Weber, K., Dowe-Keval, M., & Rogers, S. R. (1985) · PubMed · Cited by 2,154
Maximal respiratory pressures: normal values and relationship to age and sex.
Black, L. F., & Hyatt, R. E. (1969) · PubMed · doi:10.1164/arrd.1969.99.5.696 · Cited by 1,877
Visser, M., Pahor, M., Taaffe, D. R., Goodpaster, B. H., Simonsick, E. M., Newman, A. B., Nevitt, M., & Harris, T. B. (2002) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/57.5.m326 · Cited by 1,294
Time Course and Recovery of Exacerbations in Patients with Chronic Obstructive Pulmonary Disease
SEEMUNGAL, T. A. R., DONALDSON, G. C., BHOWMIK, A., JEFFRIES, D. J., & WEDZICHA, J. A. (2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.161.5.9908022 · Cited by 1,179
Peripheral muscle weakness contributes to exercise limitation in COPD.
Gosselink, R., Troosters, T., & Decramer, M. (1996) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.153.3.8630582 · Cited by 1,027
Prevalence of sarcopenia and predictors of skeletal muscle mass in healthy, older men and women
Iannuzzi-Sucich, M., Prestwood, K. M., & Kenny, A. M. (2002) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/57.12.m772 · Cited by 890
Cited by
Spruit, M. A., Singh, S. J., Garvey, C., ZuWallack, R., Nici, L., Rochester, C., Hill, K., Holland, A. E., Lareau, S. C., Man, W. D.-C., et al. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201309-1634st · Cited by 3,938
Self-citationAmerican Thoracic Society/European Respiratory Society statement on pulmonary rehabilitation
Nici, L., Donner, C., Wouters, E., Zuwallack, R., Ambrosino, N., Bourbeau, J., Carone, M., Celli, B., Engelen, M., Fahy, B., et al. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200508-1211st · Cited by 1,966
Systemic manifestations and comorbidities of COPD
Barnes, P. J., & Celli, B. R. (2009) · European Respiratory Journal · doi:10.1183/09031936.00128008 · Cited by 1,820
COPD exacerbations: Defining their cause and prevention
Wedzicha, J. A., & Seemungal, T. A. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61382-8 · Cited by 1,370
“Spruit and colleagues 64 have shown that peripheral muscle weakness worsens during exacerbation, potentially contributing to reduced functionality and therefore to deconditioning (loss of fi tness).”
Maltais, F., Decramer, M., Casaburi, R., Barreiro, E., Burelle, Y., Debigaré, R., Dekhuijzen, P. N. R., Franssen, F., Gayan-Ramirez, G., Gea, J., et al. (2014) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201402-0373st · Cited by 1,090
Self-citationPulmonary rehabilitation following exacerbations of chronic obstructive pulmonary disease
Puhan, M. A., Gimeno-Santos, E., Cates, C. J., & Troosters, T. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005305.pub4 · Cited by 991
Swallow, E. B., Reyes, D., Hopkinson, N. S., Man, W. D.-C., Porcher, R., Cetti, E. J., Moore, A. J., Moxham, J., & Polkey, M. I. (2007) · Thorax · doi:10.1136/thx.2006.062026 · Cited by 728
Mediators of Chronic Obstructive Pulmonary Disease
Barnes, P. J. (2004) · Pharmacological Reviews · doi:10.1124/pr.56.4.2 · Cited by 710
Physical Activity and Hospitalization for Exacerbation of COPD
Pitta, F., Troosters, T., Probst, V. S., Spruit, M. A., Decramer, M., & Gosselink, R. (2006) · Chest · doi:10.1378/chest.129.3.536 · Cited by 688
Self-citationPulmonary Rehabilitation in Chronic Obstructive Pulmonary Disease
Troosters, T., Casaburi, R., Gosselink, R., & Decramer, M. (2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200408-1109so · Cited by 649
Cellular and Molecular Mechanisms of Chronic Obstructive Pulmonary Disease
Barnes, P. J. (2014) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2013.10.004 · Cited by 488
Airway and Systemic Inflammation and Decline in Lung Function in Patients With COPD
Donaldson, G. C., Seemungal, T. A. R., Patel, I. S., Bhowmik, A., Wilkinson, T. M. A., Hurst, J. R., MacCallum, P. K., & Wedzicha, J. A. (2005) · Chest · doi:10.1378/chest.128.4.1995 · Cited by 480
Use of Plasma Biomarkers at Exacerbation of Chronic Obstructive Pulmonary Disease
Hurst, J. R., Donaldson, G. C., Perera, W. R., Wilkinson, T. M. A., Bilello, J. A., Hagan, G. W., Vessey, R. S., & Wedzicha, J. A. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200604-506oc · Cited by 454
Hypoxemia in patients with COPD: cause, effects, and disease progression
McNicholas, W., Kent, & Mitchell (2011) · International Journal of Chronic Obstructive Pulmonary Disease · doi:10.2147/copd.s10611 · Cited by 434
Spruit, M. A., Holland, A. E., Singh, S. J., Tonia, T., Wilson, K. C., & Troosters, T. (2020) · European Respiratory Journal · doi:10.1183/13993003.02197-2020 · Cited by 422
Self-citationRitchie, A. I., & Wedzicha, J. A. (2020) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2020.06.007 · Cited by 402
Pulmonary rehabilitation following exacerbations of chronic obstructive pulmonary disease
Puhan, M. A., Gimeno-Santos, E., Scharplatz, M., Troosters, T., Walters, E. H., & Steurer, J. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005305.pub3 · Cited by 379
MacLeod, M., Papi, A., Contoli, M., Beghé, B., Celli, B. R., Wedzicha, J. A., & Fabbri, L. M. (2021) · Respirology · doi:10.1111/resp.14041 · Cited by 359
Belli, S., Balbi, B., Prince, I., Cattaneo, D., Masocco, F., Zaccaria, S., Bertalli, L., Cattini, F., Lomazzo, A., Dal Negro, F., et al. (2020) · European Respiratory Journal · doi:10.1183/13993003.02096-2020 · Cited by 320
Self-citationD-C Man, W., Polkey, M. I., Donaldson, N., Gray, B. J., & Moxham, J. (2004) · BMJ · doi:10.1136/bmj.38258.662720.3a · Cited by 317
Exacerbations and Time Spent Outdoors in Chronic Obstructive Pulmonary Disease
Donaldson, G. C., Wilkinson, T. M. A., Hurst, J. R., Perera, W. R., & Wedzicha, J. A. (2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200408-1054oc · Cited by 316
Jaitovich, A., & Barreiro, E. (2018) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201710-2140ci · Cited by 303
Decramer, M., Rennard, S., Troosters, T., Mapel, D. W., Giardino, N., Mannino, D., Wouters, E., Sethi, S., & Cooper, C. B. (2008) · COPD: Journal of Chronic Obstructive Pulmonary Disease · doi:10.1080/15412550802237531 · Cited by 295
Chronic obstructive pulmonary disease and comorbidities
Decramer, M., & Janssens, W. (2013) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(12)70060-7 · Cited by 291
Greening, N. J., Williams, J. E. A., Hussain, S. F., Harvey-Dunstan, T. C., Bankart, M. J., Chaplin, E. J., Vincent, E. E., Chimera, R., Morgan, M. D., Singh, S. J., et al. (2014) · BMJ · doi:10.1136/bmj.g4315 · Cited by 289
Outpatient pulmonary rehabilitation following acute exacerbations of COPD
Seymour, J. M., Moore, L., Jolley, C. J., Ward, K., Creasey, J., Steier, J. S., Yung, B., Man, W. D. C., Hart, N., Polkey, M. I., et al. (2010) · Thorax · doi:10.1136/thx.2009.124164 · Cited by 282
Sarcopenia in COPD: a systematic review and meta-analysis
Benz, E., Trajanoska, K., Lahousse, L., Schoufour, J. D., Terzikhan, N., De Roos, E., de Jonge, G. B., Williams, R., Franco, O. H., Brusselle, G., et al. (2019) · European Respiratory Review · doi:10.1183/16000617.0049-2019 · Cited by 265
COPD: current therapeutic interventions and future approaches
Barnes, P. J., & Stockley, R. A. (2005) · European Respiratory Journal · doi:10.1183/09031936.05.00139104 · Cited by 259
Mechanisms and impact of the frequent exacerbator phenotype in chronic obstructive pulmonary disease
Wedzicha, J. A., Brill, S. E., Allinson, J. P., & Donaldson, G. C. (2013) · BMC Medicine · doi:10.1186/1741-7015-11-181 · Cited by 253
Muscle Atrophy and Hypertrophy Signaling in Patients with Chronic Obstructive Pulmonary Disease
Doucet, M., Russell, A. P., Léger, B., Debigaré, R., Joanisse, D. R., Caron, M.-A., LeBlanc, P., & Maltais, F. (2007) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200605-704oc · Cited by 243
Skeletal muscle dysfunction in patients with chronic obstructive pulmonary disease
Hussain, S., Cheol, K., & Mofarrahi, M. (2008) · International Journal of Chronic Obstructive Pulmonary Disease · doi:10.2147/copd.s4480 · Cited by 224
Exercise training and pulmonary rehabilitation: new insights and remaining challenges
Troosters, T., Gosselink, R., Janssens, W., & Decramer, M. (2010) · European Respiratory Review · doi:10.1183/09059180.00007809 · Cited by 138
Self-citationCrul, T., Spruit, M. A., Gayan‐Ramirez, G., Quarck, R., Gosselink, R., Troosters, T., Pitta, F., & Decramer, M. (2007) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2007.01867.x · Cited by 117
Self-citationRETRACTED: Effects of Omega-3 Polyunsaturated Fatty Acids on Inflammatory Markers in COPD
Matsuyama, W., Mitsuyama, H., Watanabe, M., Oonakahara, K.-I., Higashimoto, I., Osame, M., & Arimura, K. (2005) · Chest · doi:10.1378/chest.128.6.3817 · Cited by 108
RetractedRabinovich, R. A., Drost, E., Manning, J. R., Dunbar, D. R., Díaz-Ramos, M., Lakhdar, R., Bastos, R., & MacNee, W. (2015) · Respiratory Research · doi:10.1186/s12931-014-0139-5 · Cited by 88
Barreiro, E., & Gea, J. (2016) · Chronic Respiratory Disease · doi:10.1177/1479972316642366 · Cited by 87
Gene Expression Profiling in Vastus Lateralis Muscle During an Acute Exacerbation of COPD
Crul, T., Testelmans, D., Spruit, M., Troosters, T., Gosselink, R., Geeraerts, I., Decramer, M., & Gayan-Ramirez, G. (2010) · Cellular Physiology and Biochemistry · doi:10.1159/000303054 · Cited by 79
Self-citationFactors Limiting Exercise Tolerance in Chronic Lung Diseases
Vogiatzis, I., & Zakynthinos, S. (2012) · Comprehensive Physiology · doi:10.1002/cphy.c110015 · Cited by 77
“Recent experimental data suggest that TNF-α interferes with the action of muscle insulin-like growth factor-I (IGF-I), thereby leading to muscle atrophy (38, 290).”
Bin, Y., Xiao, Y., Huang, D., Ma, Z., Liang, Y., Bai, J., Zhang, W., Liang, Q., Zhang, J., Zhong, X., et al. (2019) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00005.2018 · Cited by 35
Ogasawara, T., Marui, S., Miura, E., Sugiura, M., Matsuyama, W., Aoshima, Y., Kasamatsu, N., Ogiku, M., & Ikematsu, Y. (2018) · Clinical Nutrition ESPEN · doi:10.1016/j.clnesp.2018.09.076 · Cited by 32
Natanek, S. A., Riddoch-Contreras, J., Marsh, G. S., Hopkinson, N. S., Moxham, J., Man, W. D.-C., Kemp, P. R., & Polkey, M. I. (2013) · COPD: Journal of Chronic Obstructive Pulmonary Disease · doi:10.3109/15412555.2013.781577 · Cited by 32
Riddoch-Contreras, J., George, T., Natanek, S. A., Marsh, G. S., Hopkinson, N. S., Tal-Singer, R., Kemp, P., & Polkey, M. I. (2012) · COPD: Journal of Chronic Obstructive Pulmonary Disease · doi:10.3109/15412555.2011.644359 · Cited by 17
“It is well known that acute exacerbation is associated with the acute development of muscle weakness (48) and reduced physical activity (49) as well as changes in the infl ammatory milieu.”
Background
Metadata
- Authors
- Spruit, M. A.
- Venue
- Thorax
- Publisher
- BMJ
- Published
- 2003-09-01
- Volume
- 58
- Issue
- 9
- Pages
- 752-756
- ISSN
- 0040-6376 (ISSN-L)
- OpenAlex
- W2098705401
- Cited by
- 476
- References
- 48
- FWCI
- 12.78
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.